The Efficacy and Safety of Anticoagulation in Chinese Patients With Non-ST Segment Elevation Acute Coronary Syndrome

NCT01271101 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1800

Last updated 2011-01-06

No results posted yet for this study

Summary

The primary objective of the EASY-CHINA Registry is to describe the clinical epidemiology of Chinese patients with NSTE-ACS, to evaluate their current anticoagulation management in China, and the resources used for it.

Conditions

  • Acute Coronary Syndrome

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Principal Investigators

  • Jinming Yu, Doctor · School of Public Health,Fudan University

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2011-03-31
Completion
2011-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01271101 on ClinicalTrials.gov